Team
Our team
Our team
Our team brings together expertise across biotech, pharmaceuticals, genomics, digital assets, AI, and capital markets. We are building BioVergence as a practical platform for scientific asset formation, financing, and commercialization.
Meet our Leaders
A new paradigm in scientific development
Raj Malholtra
Co-founder & CEO
Raj Malholtra
Co-founder & CEO
Vijay Chandru
Co-founder & Chairman
Vijay Chandru
Co-founder & Chairman
Ezhil Subbian
Synthetic Biology
Ezhil Subbian
Synthetic Biology
Kurt Stoeckli
Strategic Advisor
Kurt Stoeckli
Strategic Advisor
Lisa Danzig
Clinical Innovation
Lisa Danzig
Clinical Innovation
Rahul Mathan
Data Infrastructure
Rahul Mathan
Data Infrastructure
Carlos Rivera Velez
Operations Head & Latin America Business Development
Carlos Rivera Velez
Operations Head & Latin America Business Development
David Barbash
Counsel, Arent Fox & Schiff
David Barbash
Counsel, Arent Fox & Schiff
Ignacio Pino
Drug Discovery
Ignacio Pino
Drug Discovery
Giovanny Acosta
R&D Infrastructure
Giovanny Acosta
R&D Infrastructure
Marcelo Samsa
RNA Platforms
Marcelo Samsa
RNA Platforms
Raffaela Ritter
Ecosystem Partnerships Lead
Raffaela Ritter
Ecosystem Partnerships Lead
Michael Nehil
Regenerative Therapeutics Lead
Michael Nehil
Regenerative Therapeutics Lead
Allisson Duggan
Chief of Staff
Allisson Duggan
Chief of Staff
Nishith Desai
Global Legal Strategy Counsel
Nishith Desai
Global Legal Strategy Counsel
Javier Vasquez
Counsel, O’Neill & Borghes
Javier Vasquez
Counsel, O’Neill & Borghes
Swati Mehta
Principal, Catalyst Fund
Swati Mehta
Principal, Catalyst Fund
Reto Luttiger
Tokenization Counsel
Reto Luttiger
Tokenization Counsel
Jose Oramas
AI Orchestration Associate
Jose Oramas
AI Orchestration Associate
Maximilien Baas-Thomas
Business Development Consultant
Maximilien Baas-Thomas
Business Development Consultant
Our direction
What we are building toward
BioVergence is designed to help scientific assets become easier to identify, underwrite, finance, and launch. Our team is united around building real infrastructure for capital formation and selective productization, not a theory project.
Dream Big. Impact Lives.
Build with us
Help shape the future of science
We are a growing ecosystem of builders, scientists, designers, token engineers, and thinkers reimagining how innovation happens.
Whether you're developing new biotech tools, curating IP, launching a modular venture, or contributing to open research infrastructure, there’s a role for you in our community.
We believe in shared ownership and the power of global collaboration. We believe the best ideas are made reality through the power of community. If you’re ready to help decentralize the future of science, join the BioVergence community.
Modular bioscience, at your fingertips
Modular bioscience, at your fingertips
Modular bioscience, at your fingertips
FAQ
Frequently asked questions
Frequently asked questions
Frequently asked questions
What is your tokenization process?
Where do the scientific assets come from?
Who is BioVergence for?
How do I get started?
Team
Our team
Our team
Our team brings together expertise across biotech, pharmaceuticals, genomics, digital assets, AI, and capital markets. We are building BioVergence as a practical platform for scientific asset formation, financing, and commercialization.
Meet our Leaders
A new paradigm in scientific development
Raj Malholtra
Co-founder & CEO
Raj Malholtra
Co-founder & CEO
Vijay Chandru
Co-founder & Chairman
Vijay Chandru
Co-founder & Chairman
Ezhil Subbian
Synthetic Biology
Ezhil Subbian
Synthetic Biology
Kurt Stoeckli
Strategic Advisor
Kurt Stoeckli
Strategic Advisor
Lisa Danzig
Clinical Innovation
Lisa Danzig
Clinical Innovation
Rahul Mathan
Data Infrastructure
Rahul Mathan
Data Infrastructure
Carlos Rivera Velez
Operations Head & Latin America Business Development
Carlos Rivera Velez
Operations Head & Latin America Business Development
David Barbash
Counsel, Arent Fox & Schiff
David Barbash
Counsel, Arent Fox & Schiff
Ignacio Pino
Drug Discovery
Ignacio Pino
Drug Discovery
Giovanny Acosta
R&D Infrastructure
Giovanny Acosta
R&D Infrastructure
Marcelo Samsa
RNA Platforms
Marcelo Samsa
RNA Platforms
Raffaela Ritter
Ecosystem Partnerships Lead
Raffaela Ritter
Ecosystem Partnerships Lead
Michael Nehil
Regenerative Therapeutics Lead
Michael Nehil
Regenerative Therapeutics Lead
Allisson Duggan
Chief of Staff
Allisson Duggan
Chief of Staff
Nishith Desai
Global Legal Strategy Counsel
Nishith Desai
Global Legal Strategy Counsel
Javier Vasquez
Counsel, O’Neill & Borghes
Javier Vasquez
Counsel, O’Neill & Borghes
Swati Mehta
Principal, Catalyst Fund
Swati Mehta
Principal, Catalyst Fund
Reto Luttiger
Tokenization Counsel
Reto Luttiger
Tokenization Counsel
Jose Oramas
AI Orchestration Associate
Jose Oramas
AI Orchestration Associate
Maximilien Baas-Thomas
Business Development Consultant
Maximilien Baas-Thomas
Business Development Consultant
Our direction
What we are building toward
BioVergence is designed to help scientific assets become easier to identify, underwrite, finance, and launch. Our team is united around building real infrastructure for capital formation and selective productization, not a theory project.
Dream Big. Impact Lives.
Build with us
Help shape the future of science
We are a growing ecosystem of builders, scientists, designers, token engineers, and thinkers reimagining how innovation happens.
Whether you're developing new biotech tools, curating IP, launching a modular venture, or contributing to open research infrastructure, there’s a role for you in our community.
We believe in shared ownership and the power of global collaboration. We believe the best ideas are made reality through the power of community. If you’re ready to help decentralize the future of science, join the BioVergence community.
Modular bioscience, at your fingertips
Modular bioscience, at your fingertips
Modular bioscience, at your fingertips
FAQ